Literature DB >> 12530939

Molecular mechanisms of angiotensin II-induced vascular injury.

Marta Ruiz-Ortega1, Monica Ruperez, Vanesa Esteban, Jesús Egido.   

Abstract

Blockers of the renin-angiotensin system are used in the treatment of several cardiovascular and renal diseases, including hypertension, atherosclerosis, and cardiac failure. Angiotensin II plays an essential role in the pathogenesis of these diseases through the regulation of cell growth, inflammation, and fibrosis. There are two main angiotensin II receptors, AT(1) and AT(2). The AT(1) receptor is responsible for most of the pathophysiologic actions of angiotensin II, including cell proliferation, production of growth factors and cytokines, and fibrosis. AT(2) causes antiproliferation and counteracts the cell growth induced by AT(1) activation. We review the mechanisms whereby AT(1) and AT(2) receptors elicit their respective actions. We discuss the current understanding of the signaling mechanisms involved in angiotensin II-induced vascular damage, describing the mediators (growth factors and cytokines) and intracellular signals (activation of protein kinases, transcription factors, and redox pathways) implicated in these processes, with special emphasis on novel information and open questions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12530939     DOI: 10.1007/s11906-003-0014-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  49 in total

1.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

Authors:  G Wolf; F N Ziyadeh; F Thaiss; J Tomaszewski; R J Caron; U Wenzel; G Zahner; U Helmchen; R A Stahl
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms.

Authors:  J Deguchi; M Makuuchi; T Nakaoka; T Collins; Y Takuwa
Journal:  Circ Res       Date:  1999-10-01       Impact factor: 17.367

3.  Detection and localization of tumor necrosis factor in human atheroma.

Authors:  P Barath; M C Fishbein; J Cao; J Berenson; R H Helfant; J S Forrester
Journal:  Am J Cardiol       Date:  1990-02-01       Impact factor: 2.778

4.  Transcriptional and translational regulation of angiotensin II type 2 receptor by angiotensin II and growth factors.

Authors:  J Y Li; O Avallet; M C Berthelon; D Langlois; J M Saez
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

5.  Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts.

Authors:  T Yokoyama; K Sekiguchi; T Tanaka; K Tomaru; M Arai; T Suzuki; R Nagai
Journal:  Am J Physiol       Date:  1999-06

6.  Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice.

Authors:  M Ruiz-Ortega; O Lorenzo; M Rupérez; Y Suzuki; J Egido
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

7.  Inflammation influences vascular remodeling through AT2 receptor expression and signaling.

Authors:  M Akishita; M Horiuchi; H Yamada; L Zhang; G Shirakami; K Tamura; Y Ouchi; V J Dzau
Journal:  Physiol Genomics       Date:  2000-01-24       Impact factor: 3.107

8.  Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors.

Authors:  M Ruiz-Ortega; O Lorenzo ; M Rupérez; J Blanco; J Egido
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

9.  Angiotensin III activates nuclear transcription factor-kappaB in cultured mesangial cells mainly via AT(2) receptors: studies with AT(1) receptor-knockout mice.

Authors:  Óscar Lorenzo; Marta Ruiz-Ortega; Yusuke Suzuki; Mónica Rupérez; Vanesa Esteban; Takeshi Sugaya; Jesús Egido
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

10.  Abnormalities of the extracellular degradation of collagen type I in essential hypertension.

Authors:  C Laviades; N Varo; J Fernández; G Mayor; M J Gil; I Monreal; J Díez
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

View more
  39 in total

1.  Mediators leading to fibrosis - how to measure and control them in tissue engineering.

Authors:  Xd Mu; Ih Bellayr; Tj Walters; Y Li
Journal:  Oper Tech Orthop       Date:  2010-06-01

2.  Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery.

Authors:  Yiping Zou; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2012-05-08       Impact factor: 2.192

Review 3.  New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.

Authors:  Roberto I Vazquez-Padron; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

4.  Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.

Authors:  Miguel L Graciano; Akira Nishiyama; Keith Jackson; Dale M Seth; Rudy M Ortiz; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-07

5.  Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.

Authors:  Raúl Rodrigues Díez; Raquel Rodrigues-Díez; Carolina Lavoz; Sandra Rayego-Mateos; Esther Civantos; Juan Rodríguez-Vita; Sergio Mezzano; Alberto Ortiz; Jesús Egido; Marta Ruiz-Ortega
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

6.  Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epithelium.

Authors:  Françoise Praddaude; Scott W Cousins; Christiane Pêcher; Maria E Marin-Castaño
Journal:  Exp Eye Res       Date:  2009-03-10       Impact factor: 3.467

7.  Orphan nuclear receptor small heterodimer partner inhibits angiotensin II- stimulated PAI-1 expression in vascular smooth muscle cells.

Authors:  Kyeong-Min Lee; Hye-Young Seo; Mi-Kyung Kim; Ae-Kyung Min; Seong-Yeol Ryu; Yoon-Nyun Kim; Young Joo Park; Hueng-Sik Choi; Ki-Up Lee; Wan-Ju Park; Keun-Gyu Park; In-Kyu Lee
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

8.  Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II.

Authors:  Gary E Striker; Francoiçe Praddaude; Oscar Alcazar; Scott W Cousins; Maria E Marin-Castaño
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-15       Impact factor: 4.249

9.  Mesenteric artery remodeling and effects of imidapril and irbesartan on it in spontaneously hypertensive rats.

Authors:  Zhong-Sheng Zhu; Jin-Ming Wang; Shao-Liang Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

10.  Role of host genetics in fibrosis.

Authors:  Georgina L Hold; Paraskevi Untiveros; Karin A Saunders; Emad M El-Omar
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.